Additive Formula 3 (Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and Adenine)
**Product type:** Human Prescription Drug
**Active ingredient:** ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
**Strength:** .03; .042; 1.1; .41; .28; .59 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL
**Dosage form:** Solution
**Route:** Intravenous
**Labeler:** Terumo BCT, Ltd
**Marketing category:** NDA (BN001214)
**Pharmacologic class:** Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE]
/api/v1/systems/ndc_fda/nodes/14537-833Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.